These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
177 related items for PubMed ID: 31502681
1. Inducible nitric oxide synthase inhibitors: A comprehensive update. Minhas R, Bansal Y, Bansal G. Med Res Rev; 2020 May; 40(3):823-855. PubMed ID: 31502681 [Abstract] [Full Text] [Related]
2. Mechanism of inducible nitric-oxide synthase dimerization inhibition by novel pyrimidine imidazoles. Nagpal L, Haque MM, Saha A, Mukherjee N, Ghosh A, Ranu BC, Stuehr DJ, Panda K. J Biol Chem; 2013 Jul 05; 288(27):19685-97. PubMed ID: 23696643 [Abstract] [Full Text] [Related]
3. Anti-inflammatory activity of the synthetic chalcone derivatives: inhibition of inducible nitric oxide synthase-catalyzed nitric oxide production from lipopolysaccharide-treated RAW 264.7 cells. Kim YH, Kim J, Park H, Kim HP. Biol Pharm Bull; 2007 Aug 05; 30(8):1450-5. PubMed ID: 17666802 [Abstract] [Full Text] [Related]
4. Inducible nitric oxide synthase: Regulation, structure, and inhibition. Cinelli MA, Do HT, Miley GP, Silverman RB. Med Res Rev; 2020 Jan 05; 40(1):158-189. PubMed ID: 31192483 [Abstract] [Full Text] [Related]
5. Novel nanomolar imidazo[4,5-b]pyridines as selective nitric oxide synthase (iNOS) inhibitors: SAR and structural insights. Grädler U, Fuchss T, Ulrich WR, Boer R, Strub A, Hesslinger C, Anézo C, Diederichs K, Zaliani A. Bioorg Med Chem Lett; 2011 Jul 15; 21(14):4228-32. PubMed ID: 21684157 [Abstract] [Full Text] [Related]
6. 1-(1,3-Benzodioxol-5-ylmethyl)-3-[4-(1H-imidazol-1-yl)phenoxy]-piperidine analogs as potent and selective inhibitors of nitric oxide formation. Wei RG, Adler M, Davey D, Ho E, Mohan R, Polokoff M, Tseng JL, Whitlow M, Xu W, Yuan S, Phillips G. Bioorg Med Chem Lett; 2007 May 01; 17(9):2499-504. PubMed ID: 17368901 [Abstract] [Full Text] [Related]
7. Mechanistic studies of inactivation of inducible nitric oxide synthase by amidines. Tang W, Li H, Poulos TL, Silverman RB. Biochemistry; 2015 Apr 21; 54(15):2530-8. PubMed ID: 25811913 [Abstract] [Full Text] [Related]
8. Selective iNOS inhibitor, ONO1714 successfully retards the development of high-cholesterol diet induced atherosclerosis by novel mechanism. Hayashi T, Matsui-Hirai H, Fukatsu A, Sumi D, Kano-Hayashi H, Rani P JA, Iguchi A. Atherosclerosis; 2006 Aug 21; 187(2):316-24. PubMed ID: 16325187 [Abstract] [Full Text] [Related]
9. Pharmacological characterization of guanidinoethyldisulphide (GED), a novel inhibitor of nitric oxide synthase with selectivity towards the inducible isoform. Szabó C, Bryk R, Zingarelli B, Southan GJ, Gahman TC, Bhat V, Salzman AL, Wolff DJ. Br J Pharmacol; 1996 Aug 21; 118(7):1659-68. PubMed ID: 8842429 [Abstract] [Full Text] [Related]
11. Inhibition of nitric oxide synthase inhibitors and lipopolysaccharide induced inducible NOS and cyclooxygenase-2 gene expressions by rutin, quercetin, and quercetin pentaacetate in RAW 264.7 macrophages. Chen YC, Shen SC, Lee WR, Hou WC, Yang LL, Lee TJ. J Cell Biochem; 2001 Aug 21; 82(4):537-48. PubMed ID: 11500931 [Abstract] [Full Text] [Related]
12. Inhibitors of protein phosphatase 1 and 2A differentially regulate the expression of inducible nitric-oxide synthase in rat astrocytes and macrophages. Pahan K, Sheikh FG, Namboodiri AM, Singh I. J Biol Chem; 1998 May 15; 273(20):12219-26. PubMed ID: 9575170 [Abstract] [Full Text] [Related]
13. Spontaneous rearrangement of aminoalkylisothioureas into mercaptoalkylguanidines, a novel class of nitric oxide synthase inhibitors with selectivity towards the inducible isoform. Southan GJ, Zingarelli B, O'Connor M, Salzman AL, Szabó C. Br J Pharmacol; 1996 Feb 15; 117(4):619-32. PubMed ID: 8646406 [Abstract] [Full Text] [Related]
14. BYK191023 (2-[2-(4-methoxy-pyridin-2-yl)-ethyl]-3h-imidazo[4,5-b]pyridine) is an NADPH- and time-dependent irreversible inhibitor of inducible nitric-oxide synthase. Tiso M, Strub A, Hesslinger C, Kenney CT, Boer R, Stuehr DJ. Mol Pharmacol; 2008 Apr 15; 73(4):1244-53. PubMed ID: 18178668 [Abstract] [Full Text] [Related]
15. Inhibition of inducible nitric-oxide synthase expression by silymarin in lipopolysaccharide-stimulated macrophages. Kang JS, Jeon YJ, Kim HM, Han SH, Yang KH. J Pharmacol Exp Ther; 2002 Jul 15; 302(1):138-44. PubMed ID: 12065710 [Abstract] [Full Text] [Related]
16. Evaluating the role of inducible nitric oxide synthase using a novel and selective inducible nitric oxide synthase inhibitor in septic lung injury produced by cecal ligation and puncture. Okamoto I, Abe M, Shibata K, Shimizu N, Sakata N, Katsuragi T, Tanaka K. Am J Respir Crit Care Med; 2000 Aug 15; 162(2 Pt 1):716-22. PubMed ID: 10934111 [Abstract] [Full Text] [Related]
17. Orazipone inhibits activation of inflammatory transcription factors nuclear factor-kappa B and signal transducer and activator of transcription 1 and decreases inducible nitric-oxide synthase expression and nitric oxide production in response to inflammatory stimuli. Sareila O, Hämäläinen M, Nissinen E, Kankaanranta H, Moilanen E. J Pharmacol Exp Ther; 2008 Feb 15; 324(2):858-66. PubMed ID: 18039960 [Abstract] [Full Text] [Related]
18. Nitric oxide inhibits inducible nitric oxide synthase mRNA expression in RAW 264.7 macrophages. Hinz B, Brune K, Pahl A. Biochem Biophys Res Commun; 2000 May 10; 271(2):353-7. PubMed ID: 10799301 [Abstract] [Full Text] [Related]
19. Contribution of nitric oxide synthase isoforms to cholinergic vasodilation in murine retinal arterioles. Gericke A, Goloborodko E, Sniatecki JJ, Steege A, Wojnowski L, Pfeiffer N. Exp Eye Res; 2013 Apr 10; 109():60-6. PubMed ID: 23434456 [Abstract] [Full Text] [Related]
20. Phenylpyrrole derivatives as neural and inducible nitric oxide synthase (nNOS and iNOS) inhibitors. López Cara LC, Camacho ME, Carrión MD, Tapias V, Gallo MA, Escames G, Acuña-Castroviejo D, Espinosa A, Entrena A. Eur J Med Chem; 2009 Jun 10; 44(6):2655-66. PubMed ID: 19117642 [Abstract] [Full Text] [Related] Page: [Next] [New Search]